Guide · Updated 2026-06-28
Reducing Biological Wound Graft Waste in the OR and Wound Center
Waste is the largest controllable cost in AWC procurement. Three levers do 80% of the work: right-sized par levels per site, disciplined JW modifier billing for discarded amount, and format selection matched to site volume.
Right-size par levels per site
Cryopreserved par at low-volume sites is the #1 source of waste in multi-facility networks. Set par to support 30 days of forecast use, not the manufacturer minimum order quantity.
JW modifier discipline
Medicare allows billing of the discarded portion of a single-use vial/graft using modifier JW. Many sites under-bill JW on skin substitutes, leaving recoverable reimbursement on the table. Train coders to apply JW on every application where partial product is discarded.
Size standardization
Standardize on 2–3 SKU sizes per product line to reduce inventory complexity and reduce mid-application size-mismatch waste.
Format selection by site volume
Cryopreserved formats only make economic sense at high-volume sites (typically >2 applications/week of the product). Below that threshold, ambient-stable lyophilized formats dominate on waste-adjusted TCO.
Key takeaways
- Par to 30-day forecast, not vendor MOQ.
- Bill JW for every discarded portion.
- Standardize to 2–3 SKU sizes per product.
- Cryopreserved only at >2 applications/week sites.
More from the playbook
Part of the 2026 Advanced Wound Graft Procurement Playbook.